Dyadic International, Inc.
NASDAQ: DYAI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mark A. Emalfarb
- Employees
- 6
- Headquarters
- Jupiter, United States
- IPO year
- 2008
- Market cap
- $26.6M
- Website
- https://www.dyadic.com
Loading DYAI…
Loading profile data…Frequently asked questions about DYAI
What does Dyadic International, Inc. (DYAI) do?
Dyadic International, Inc. operates as a U.S.-based biotechnology platform company, specializing in the development, production, and commercialization of enzymes and other proteins. Its core activities are underpinned by a patented and proprietary C1 platform, alongside other advanced technologies. This technological foundation drives their rese...
Where does DYAI trade?
Dyadic International, Inc. (DYAI) trades on the NASDAQ Capital Market.
What sector is DYAI in?
Dyadic International, Inc. (DYAI) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Dyadic International, Inc.?
Mark A. Emalfarb is the chief executive officer of Dyadic International, Inc. (DYAI).
Where is Dyadic International, Inc. headquartered?
Dyadic International, Inc. is headquartered in United States.
Does DYAI pay a dividend?
Dyadic International, Inc. (DYAI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did DYAI go public?
Dyadic International, Inc. (DYAI) completed its initial public offering in 2008.